These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A bis-boron boramino acid PET tracer for brain tumor diagnosis. Li Z; Chen J; Kong Z; Shi Y; Xu M; Mu BS; Li N; Ma W; Yang Z; Wang Y; Liu Z Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1703-1712. PubMed ID: 38191817 [TBL] [Abstract][Full Text] [Related]
26. First Evaluation of PET-Based Human Biodistribution and Dosimetry of Savi A; Incerti E; Fallanca F; Bettinardi V; Rossetti F; Monterisi C; Compierchio A; Negri G; Zannini P; Gianolli L; Picchio M J Nucl Med; 2017 Aug; 58(8):1224-1229. PubMed ID: 28209906 [No Abstract] [Full Text] [Related]
27. Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [ Delva A; Koole M; Serdons K; Bormans G; Liu L; Bard J; Khetarpal V; Dominguez C; Munoz-Sanjuan I; Wood A; Skinbjerg M; Wang Y; Vandenberghe W; Van Laere K Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):48-60. PubMed ID: 36001116 [TBL] [Abstract][Full Text] [Related]
28. A microdose clinical trial to evaluate [ Lee I; Lim I; Byun BH; Kim BI; Choi CW; Woo SK; Lee KC; Kang JH; Kil HS; Park C; Chi DY; Park J; Song K; Lim SM Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):95-102. PubMed ID: 32458006 [TBL] [Abstract][Full Text] [Related]
29. Biodistribution of a Mitochondrial Metabolic Tracer, [ Levi J; Duan H; Yaghoubi S; Packiasamy J; Huynh L; Lam T; Shaikh F; Behera D; Song H; Blecha J; Jivan S; Seo Y; VanBrocklin HF Mol Imaging; 2022; 2022():3667417. PubMed ID: 36072652 [TBL] [Abstract][Full Text] [Related]
30. Radiation dosimetry of [ Lee N; Oh I; Chae SY; Jin S; Oh SJ; Lee SJ; Koglin N; Berndt M; Stephens AW; Oh JS; Moon DH Nucl Med Biol; 2019; 72-73():45-48. PubMed ID: 31330411 [TBL] [Abstract][Full Text] [Related]
31. Human biodistribution and radiation dosimetry of [ Beinat C; Patel CB; Haywood T; Shen B; Naya L; Gandhi H; Holley D; Khalighi M; Iagaru A; Davidzon G; Gambhir SS Eur J Nucl Med Mol Imaging; 2020 Aug; 47(9):2123-2130. PubMed ID: 31938892 [TBL] [Abstract][Full Text] [Related]
33. Preclinical evaluation of an Yang X; Liu Z; Zhang H; Li Z; Munasinghe JP; Niu G; Teng G; Chen X Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):585-592. PubMed ID: 29285548 [TBL] [Abstract][Full Text] [Related]
34. PET Using a GRPR Antagonist Zhang J; Niu G; Fan X; Lang L; Hou G; Chen L; Wu H; Zhu Z; Li F; Chen X J Nucl Med; 2018 Jun; 59(6):922-928. PubMed ID: 29123014 [TBL] [Abstract][Full Text] [Related]
35. Biodistribution, pharmacokinetics, dosimetry of [ Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Tripathi M; ArunRaj ST; Sarswat S; Bal C Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1915-1931. PubMed ID: 33244617 [TBL] [Abstract][Full Text] [Related]
36. Phase I clinical study of NMB58, a novel positron emission tomography (PET)-myocardial perfusion imaging tracer, conducted to evaluate its safety and pharmacokinetics in Japanese healthy adult males. Kawano M; Tsuchiya J; Bae H; Kimura K; Yokoyama K; Takahashi M; Honda M; Tominaga M; Tateishi U Ann Nucl Med; 2021 May; 35(5):580-588. PubMed ID: 33649886 [TBL] [Abstract][Full Text] [Related]
37. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas. Li DL; Xu YK; Wang QS; Wu HB; Li HS Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472 [TBL] [Abstract][Full Text] [Related]
38. Prognostic Value of O-(2-[ Kertels O; Kessler AF; Mihovilovic MI; Stolzenburg A; Linsenmann T; Samnick S; Brändlein S; Monoranu CM; Ernestus RI; Buck AK; Löhr M; Lapa C Mol Imaging Biol; 2019 Dec; 21(6):1174-1181. PubMed ID: 30977078 [TBL] [Abstract][Full Text] [Related]